Article
Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment
bioRxiv · 2018 · Eeva Sliz
Key facts
| Title | Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment |
|---|---|
| First author | Eeva Sliz |
| Journal | bioRxiv |
| Published | Mar 14, 2018 |
| DOI | 10.1101/278861 |
| Devices mentioned | 088158, 202922, K000568, K033610, K143691, K162593, K963213 |
| Product codes mentioned | DER, DFC, LBR, LBS, LBT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1